About
Orlucent develops a handheld fluorescent molecular imaging system that non-invasively detects biological markers associated with early melanoma development to improve the accuracy of mole evaluation and reduce unnecessary biopsies.
Explore Orlucent's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.